Challenging the boundaries: c9orf72 mutation presenting as Alzheimer's disease

Federico Garrou, Fabiola DE MARCHI, Lucia CORRADO, Gian Mauro Sacchetti, Sandra D'ALFONSO, Silvia Daniela Morbelli, Daniela Perani, Letizia Mazzini, Giacomo Tondo

Risultato della ricerca: Contributo su rivistaArticolo in rivistapeer review

Abstract

C9orf72 hexanucleotide repeat expansion is a major cause of Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD), while its link with Alzheimer’s disease (AD) is still unclear. We describe the case of a 53-year-old man with progressive memory and language deficits, mood disturbances, and a positive family history for ALS–FTD. Cerebrospinal fluid showed amyloid positivity, confirmed by amyloid-PET, with normal tau levels; [18F]FDG-PET revealed an AD-like temporoparietal hypometabolism. Genetic testing detected a pathogenic C9orf72 expansion, also present in his mother. This case suggests phenotypic heterogeneity of C9orf72-related disorders and a possible interplay with amyloid pathology.
Lingua originaleInglese
pagine (da-a)1-4
Numero di pagine4
RivistaAmyotrophic Lateral Sclerosis and Frontotemporal Degeneration
Volume6
DOI
Stato di pubblicazionePubblicato - 2025

Keywords

  • ALS
  • Alzheimer’s disease
  • C9orf72
  • CSF biomarkers
  • FDGPET
  • FTD
  • Flutemetamol
  • amyloid PET
  • behavioral symptoms
  • cognitive impairment
  • early-onset Alzheimer’s disease
  • genetic testing
  • neurodegeneration
  • neuroimaging
  • precision medicine

Fingerprint

Entra nei temi di ricerca di 'Challenging the boundaries: c9orf72 mutation presenting as Alzheimer's disease'. Insieme formano una fingerprint unica.

Cita questo